Pages

Thursday, September 30, 2021

Part 4. What does Portugal's success with vaccine protection say about the future of COVID-19 in Australia?


 Key message: Vaccines act two ways to decrease mortality from COVID-19 : they decrease both the chance of infection and -- as demonstrated here -- the chance of death if you get infected.


Updated 2-Oct-2021, 6-Oct-2021.

This post continues a theme investigating COVID-19 harm reduction in the major Australian population centres -- Sydney and Melbourne.

These cities are in the middle of rapid vaccine rollouts in the midst of surging coronavirus infection numbers.

Portugal have been there already, with their marvellous progress highlighted in the Financial Times 28 September 2021 by Peter Wise.

Portugal emerges as Europe’s vaccination frontrunner after public health drive

A former submarine commander has instilled confidence in jab programme that had a faltering start

Here are graphical summaries of what has happened in Portugal from the superb Our World in Data website:


After the first moderate wave of cases in March-April 2020 there was a large surge in winter 2020-21, followed by a smaller surge in cases in the late summer of 2021, that slowed as the vaccination coverage became substantially complete in mid-September 2021.

The effect of vaccination rollout is best seen from daily case numbers and double dose vaccination percentages in this graph:

Daily cases stopped increasing on 21 July 2021. About 2 week s earlier full vaccine coverage hit 40 percent so, as expected, with 40 percent of people fully immune, virus transmission started to falter. At 80 percent vaccine coverage daily cases were a small fraction of the summer peak.

The message is that 40 percent full vaccine coverage plus continued further rollout should be enough to tame Melbourne's current surge of COVID-19.

According to https://www.covid19data.com.au/vaccines New South Wales reached 40.7 percent 2-dose vaccine coverage on 17 Sept 2021. Victoria reached a similar level 30 September. Peak daily cases were seen around 10 September in Sydney. If these trends are meaningful the second week in October should show improvement in Melbourne.

Effects of vaccine on disease severity

Deaths are one measure of the severity of these waves of infections:


The graph show the mortality impact of the Portuguese winter 2020-21 case surge was awful, with around 14,000 people losing their lives. But the late summer infection wave impact on loss of life was relatively marginal.

This means that infection fatality ratios (deaths per 100 infections) changed  significantly for the better between these waves.

A direct way of calculating how deaths per 100 infections changes is to examine the relationship between deaths and case numbers in a graph. The infection fatality ratio is directly related to the slope of lines in such a graph.

For the Portugal outbreaks using numbers for cumulative deaths and cumulative cases from Our World in Data, we get this graph:

11 day lag adjustment applied to deaths
Black arrow indicates onset of fully protected immunisation

The most distinctive feature of this graph is the change in slope just after 800,000 cases, indicating a dramatic drop in mortality per 100 infections .

The slope between 400,000 cases and 600,000 cases gives a death rate of 2.54 deaths per 100 infections.

The slope from 900,000 cases to 1,060,000 cases is 0.46 deaths per 100 infections

(This compare with fatality rates of 0.7 percent in the Sydney 2021 outbreak and 0.51 in Melbourne Delta 2 outbreak)

Its useful to also check the rollout of full vaccination coverage in Portugal:

Comparison of this graph with the previous one shows that high vaccine coverage of the population was not needed to cause a drop in mortality rates. Probably this was achieved by preferential immunisation of the elderly early in the campaign, and some protection from just one jab of vaccine.

The mortality rate is not so far undergoing any further change from 0.46 percent as coverage reaches 80 out of 100 people. Perhaps we won't get much further decrease in death rate from COVID in Australia below 0.4 percent. (But likely we are a younger and less vulnerable population than Portugal -- that's a topic for another day.)

The Financial Times show that the 7 most vaccinated countries are all competing for the lowest death rates: 


Here is a comparison of countries with high vaccine rollout (thanks Eric Topol on Twitter).
The top three countries in this panel have avoided a significant last wave of infection (10 Oct 2021). Not so, the countries lower down on the list.



Total deaths are affected by both fatality rates and total infection numbers, and low infection numbers are crucial for reducing harm.


With vaccination rollout, daily new case numbers of COVID-19 infections in Portugal are dropping, off as are daily increases in total deaths, as shown in the earlier  graphs. The bottom line is that high vaccination coverage is bringing infections to a halt in Portugal, and uninfected people don't die from COVID-19. And vaccination, by protection of the vulnerable, has decreased the chance of death, if infected, from around 2.5 percent to 0.5 percent.

Vaccines act two ways to decrease mortality from COVID-19 : they decrease both the chance of infection and -- as demonstrated here -- the chance of death if you get infected.


Update 1900 hrs 30 Sept 2021

Our World in Data provide information on weekly hospitalisation in Portugal. This enables examination of whether vaccination has an effect on rates of entry into hospital of people given a COVID-19 diagnosis:

Black arrow indicates a point in the curve where a change of slope indicates decreased rates of hospitalisation from COVID-19

Examination of the slopes shows that after the point indicated by the black arrow, rates of hospitalisation of  infected persons were 2.8 fold lower. At this point vaccination fully effective coverage was above 30 percent.

Australia should be reaping these extra benefits from vaccines already.

Equivalent approximate 30 percent full immunity coverage is expected to have occurred around 12 September 2021 in New South Wales and 16 September in Victoria. Hopefully both Australian states are getting further respite in terms of hospital case load from this source of damage mitigation relief that reduces the proportion of infected people needing to go the hospital.

This graph below taken from an earlier GMO Pundit post shows the time series of weekly hospitalisation ratios to cases in New South Wales. A black arrow indicates the approximate time at which full suppression of disease severity by vaccines is expected to kick in.

Week 36 ends 11 September 2021

Looks to the Pundit that vaccines arrived in the nick of time to mitigate some disease severity in Sydney. And if indeed we get 15 percent necessary hospitalisation rates even with substantial vaccine softening of disease severity, it definitely means that the COVID delta variant disease is a truly nasty beast.


Afternote 1 Oct 2021

The harmfulness of the Delta variant in Sydney was more extensively discussed in an August 27 2021  GMO Pundit Post:

A very recent pre-print publication from Washington state further confirms some of the vaccine benefits noted in these posts.

It has an instructive diagram showing difference in risks as ratios:


This is further evidence that the SARS-CoV2 delta variant strain has increased virulence that increases the need for patient hospitalisation above that of early pandemic strains.

Preprint: Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study

Interpretation: Infection with a Variant of Concern [including Delta] results in a higher hospitalization risk, with an active vaccination attenuating that risk. Our findings support promoting hospital preparedness, vaccination, and robust genomic surveillance.

 Miguel I. Paredes 1,2* , Stephanie M. Lunn3 , Michael Famulare 4 , Lauren A. Frisbie 3 , Ian Painter, 3 , Roy Burstein 4 , Pavitra Roychoudhury 2,5, Hong Xie 5 , Shah A. Mohamed Bakhash 5 , Ricardo Perez 5 , Maria Lukes 5 , Sean Ellis 5 , Saraswathi Sathees 5 , Patrick Mathias, 5 , Alexander Greninger, 2,5, Lea M. Starita 6,7 , Chris D. Frazar 6 , Erica Ryke 6 , Weizhi Zhong 7 , Luis Gamboa 7 , Machiko Threlkeld 6 , Jover Lee  , Deborah A. Nickerson 6,7, Daniel L. Bates 8 , Matthew E. Hartman 8,9, Eric Haugen 8 , Truong N. Nguyen 8 , Joshua D. Richards 8 , Jacob L. Rodriguez 8 , John A. Stamatoyannopoulos 8 , Eric Thorland 8 , Geoff Melly 3 , Philip E. Dykema 3 , Drew C. MacKellar 3 , Hannah K. Gray 3 , Avi Singh 3 , JohnAric MoonDance Peterson 3 , Denny Russell 3 , Laura Marcela Torres 3 , Scott Lindquist 3 , Trevor Bedford 1,2,6, Krisandra J. Allen 3 , Hanna N. Oltean 3*

https://www.medrxiv.org/content/10.1101/2021.09.29.21264272v1.full.pdf

 

Update 11 Jan 2022




No comments:

Post a Comment